SCHEMBL17569733

SCHEMBL17569733

CC(C)(C)OC(=O)/N=C(/NC(=O)OC(C)(C)C)Nc1cccc(N)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.47
DDX3X O00571 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.40
PTGS1 P23219 3/20 0.40
CYP17A1 P05093 1/20 0.39
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
HDAC1 Q13547 3/20 0.38
HDAC3 O15379 2/20 0.38
HDAC2 Q92769 2/20 0.38
HDAC8 Q9BY41 2/20 0.38
HDAC6 Q9UBN7 2/20 0.38
HDAC4 P56524 2/20 0.38
MAPT P10636 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC10 Q969S8 1/20 0.38
HDAC11 Q96DB2 1/20 0.38
HDAC9 Q9UKV0 1/20 0.38
HDAC5 Q9UQL6 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19275814 1.00 ALDH1A1 (0.47) ALDH1A1DDX3XSMN1; SMN2PTGS1CYP17A1
SCHEMBL20057655 0.88 CYP17A1 (0.39) ALDH1A1CYP17A1CA1CA2HDAC1
SCHEMBL25835220 0.86 PARP14 (0.47) ALDH1A1CYP17A1HDAC1HDAC3HDAC2
SCHEMBL16355923 0.85 MEN1 (0.44) ALDH1A1MAPTRXFP1
SCHEMBL29803908 0.85 MAP4K4 (0.40) CYP17A1CA1CA2MAPTMAPK14
SCHEMBL3785113 0.84 CTSK (0.41) ALDH1A1CYP17A1CA1HDAC1HDAC4
SCHEMBL13785635 0.84 CTSK (0.41) ALDH1A1CYP17A1CA1HDAC1HDAC4
SCHEMBL3785111 0.84 CTSK (0.41) ALDH1A1CYP17A1CA1HDAC1HDAC4
SCHEMBL23455432 0.84 RAB9A (0.50) ALDH1A1SMN1; SMN2HDAC1HDAC3HDAC2
SCHEMBL23455430 0.84 RAB9A (0.50) ALDH1A1SMN1; SMN2HDAC1HDAC3HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016034642-A1 ISOQUINOLINONE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER PIERRE FABRE MEDICAMENT (FR) 2016-03-10 WO disclosed